NHS COVID-19

From WikiMD's WELLNESSPEDIA

NHS COVID-19 is a mobile application developed by the National Health Service (NHS) in the United Kingdom. The app is designed to assist in the tracking and tracing of the COVID-19 pandemic. It was launched on 24 September 2020 in England and Wales.

Overview[edit]

The NHS COVID-19 app is part of the larger NHS Test and Trace service in England and the NHS Wales Test, Trace, Protect service in Wales. The app is designed to alert users if they have been in close contact with someone who has tested positive for COVID-19. It also allows users to report symptoms, order a coronavirus test, and check in to venues using a QR code.

Development and Features[edit]

The app was developed by the digital transformation unit of the NHS, NHSX, with the aim of slowing the spread of COVID-19. The app uses Bluetooth technology to keep an anonymous log of people a user has been in close contact with. If a user tests positive for COVID-19, the app sends an anonymous alert to those contacts.

The NHS COVID-19 app also includes a number of additional features designed to help manage the COVID-19 pandemic. These include risk alerts by postcode, a symptom checker, and a QR code check-in system at venues.

Reception and Impact[edit]

The NHS COVID-19 app has been downloaded over 10 million times since its launch. However, it has also faced criticism and controversy, particularly around issues of privacy and effectiveness.

See Also[edit]

References[edit]


Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=NHS_COVID-19&oldid=6333123"